content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001843167</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001837607</issuerCik>
        <issuerName>AEON Biopharma, Inc.</issuerName>
        <secFileNumber>001-40021</secFileNumber>
        <issuerAddress>
          <com:street1>5 Park Plaza, Suite 1750</com:street1>
          <com:city>Irvine</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>82614</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>949-354-6499</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Oleg Grodnensky</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Affiliate</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue</com:street1>
            <com:street2>6th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>201825</noOfUnitsSold>
        <aggregateMarketValue>530780</aggregateMarketValue>
        <noOfUnitsOutstanding>39522238</noOfUnitsOutstanding>
        <approxSaleDate>07/29/2024</approxSaleDate>
        <securitiesExchangeName>NYSE</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>07/21/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Exercise of Warrants 03/29/2024</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>201825</amountOfSecuritiesAcquired>
        <paymentDate>03/29/2024</paymentDate>
        <natureOfPayment>Cashless exercise</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>07/29/2024</noticeDate>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Oleg Grodnensky</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2886}]
text: 144
  0001843167
  XXXXXXXX
  LIVE
  0001837607
  AEON Biopharma, Inc.
  001-40021
  5 Park Plaza, Suite 1750
  Irvine
  CA
  82614
  949-354-6499
  Oleg Grodnensky
  Affiliate
  Common Stock
  J.P. Morgan Securities LLC
  390 Madison Avenue
  6th Floor
  New York
  NY
  10017
  201825
  530780
  39522238
  07/29/2024
  NYSE
  Common Stock
  07/21/2023
  Exercise of Warrants 03/29/2024
  Issuer
  N
  201825
  03/29/2024
  Cashless exercise
  Y
  07/29/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Oleg Grodnensky